JPH0341492B2 - - Google Patents
Info
- Publication number
- JPH0341492B2 JPH0341492B2 JP55178075A JP17807580A JPH0341492B2 JP H0341492 B2 JPH0341492 B2 JP H0341492B2 JP 55178075 A JP55178075 A JP 55178075A JP 17807580 A JP17807580 A JP 17807580A JP H0341492 B2 JPH0341492 B2 JP H0341492B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- present
- sheet
- germanium
- macromolecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002291 germanium compounds Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 description 31
- 229920002521 macromolecule Polymers 0.000 description 12
- 239000013078 crystal Substances 0.000 description 11
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000004455 differential thermal analysis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 4
- 229960004857 mitomycin Drugs 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- ZJUHNMADISSFJZ-UHFFFAOYSA-N 2-trichlorogermylpropanoic acid Chemical compound OC(=O)C(C)[Ge](Cl)(Cl)Cl ZJUHNMADISSFJZ-UHFFFAOYSA-N 0.000 description 3
- NLIJOIUVZBYQRS-UHFFFAOYSA-N 3-trichlorogermylpropanoic acid Chemical compound OC(=O)CC[Ge](Cl)(Cl)Cl NLIJOIUVZBYQRS-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000005760 tumorsuppression Effects 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- XRYJTKGEJGVBCC-UHFFFAOYSA-N 2-germylpropanoic acid Chemical compound CC([GeH3])C(O)=O XRYJTKGEJGVBCC-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- -1 organogermanium compound Chemical class 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- MUDDKLJPADVVKF-UHFFFAOYSA-N trichlorogermane Chemical compound Cl[GeH](Cl)Cl MUDDKLJPADVVKF-UHFFFAOYSA-N 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- KHDSWONFYIAAPE-UHFFFAOYSA-N silicon sulfide Chemical compound S=[Si]=S KHDSWONFYIAAPE-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940035339 tri-chlor Drugs 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55178075A JPS57102895A (en) | 1980-12-18 | 1980-12-18 | Organogermanium compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55178075A JPS57102895A (en) | 1980-12-18 | 1980-12-18 | Organogermanium compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57102895A JPS57102895A (en) | 1982-06-26 |
| JPH0341492B2 true JPH0341492B2 (enrdf_load_stackoverflow) | 1991-06-24 |
Family
ID=16042175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55178075A Granted JPS57102895A (en) | 1980-12-18 | 1980-12-18 | Organogermanium compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57102895A (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5936997B2 (ja) * | 1981-11-16 | 1984-09-06 | 隆一 佐藤 | 有機ゲルマニウム重合体 |
| JPS5936998B2 (ja) * | 1981-11-16 | 1984-09-06 | 隆一 佐藤 | 有機ゲルマニウム重合体 |
| US4973553A (en) * | 1987-09-09 | 1990-11-27 | Asai Germanium Research Institute | Salt or organogermanium compound and medicine containing the same |
| WO2021080019A1 (ja) | 2019-10-24 | 2021-04-29 | 株式会社浅井ゲルマニウム研究所 | 新規有機ゲルマニウム化合物 |
-
1980
- 1980-12-18 JP JP55178075A patent/JPS57102895A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57102895A (en) | 1982-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sweeney et al. | Novel benzyl substituted titanocene anti-cancer drugs | |
| KR101372659B1 (ko) | 포스핀 전이 금속 착체, 그의 제조 방법 및 항암제 | |
| TW200300671A (en) | Paclitaxel solvates | |
| CN113527370B (zh) | 一种靶向于肺癌顺铂耐药细胞的喹啉铱配合物及其合成方法和应用 | |
| CN101402655B (zh) | 一种米铂的制备方法 | |
| JPH0341492B2 (enrdf_load_stackoverflow) | ||
| JP5090180B2 (ja) | ホスフィン遷移金属錯体、その製造方法およびそれを含有する抗癌剤 | |
| JPS6158449B2 (enrdf_load_stackoverflow) | ||
| EP0176005B1 (en) | Novel platinum complexes | |
| US4822817A (en) | Remedy for bone disease | |
| JP2004502696A (ja) | 癌治療用のルテニウム（ｉｉ）化合物 | |
| FI88165B (fi) | Foerfarande foer framstaellning av cis-diammin-1,1-cyklobutandikarboxylat-platina(ii)komplex | |
| CN114437128B (zh) | 一种胆碱磷酸修饰的紫杉醇药物及其制备方法和应用 | |
| Fedorova et al. | A novel route to triphenylgermyl europium complexes. Crystal structure of (Ph3Ge) 2Eu (DME) 3 | |
| JP6887195B1 (ja) | 新規有機ゲルマニウム化合物 | |
| JPS6329888B2 (enrdf_load_stackoverflow) | ||
| RU2054286C1 (ru) | Платиновый цитостатик и способ его получения | |
| US3764673A (en) | Pharmaceutical compositions comprising alkylsilyl ethers of prostaglandins | |
| JPS5933292A (ja) | 有機ゲルマニウム化合物 | |
| SU690002A1 (ru) | Способ получени 4-метокси-1,2нафтохинона | |
| CN112585149B (zh) | 膦过渡金属配位化合物、其制造方法和抗癌剂 | |
| Noh et al. | Stepwise formation of cyclodimer and cage via decomposition of hexafluorophosphate anion. Structures and related properties of (2, 2′-bipyridine) palladium (II) complexes of 1, 3, 5-tris (nicotinoyloxyethyl) cyanurate | |
| CN1303854A (zh) | 中位带有烷氧基苯基的四苯并卟啉金属配位化合物及合成 | |
| KR101243609B1 (ko) | 유기 게르마늄 나노구조체 및 이의 제조방법 | |
| JP6486639B2 (ja) | 金属錯体およびこれを含有する抗癌剤 |